Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision HD-tACS-Based Therapy for the Qualitative and Phenomenological Enhancement of Sensory Experiences in Schizophrenia

NCT07632261 is registered in ClinicalTrials.gov with Hôpital le Vinatier as lead sponsor.

NCT NCT07632261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07632261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision HD-tACS-Based Therapy for the Qualitative and Phenomenological Enhancement of Sensory Experiences in Schizophrenia
Lead sponsor
Hôpital le Vinatier
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 15, 2026
Completion date
May 1, 2030
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia 1 (disorder), sensory perceptual characteristics